Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Part 1, the pharmacokinetic (PK) phase, will expand upon the pilot study conducted at Naval
Medical Research Laboratory (NAMRL) and has the goal of determining bioavailability and time
to Cmax in a larger representative sample. Part 2, the efficacy phase, is to determine the
efficacy of the aqueous spray solution via exposure to a nausea-inducing stimulus.